(Total Views: 49)
Posted On: 06/26/2025 8:33:31 AM
Post# of 99237
$FUNR to Disrupt Telemedicine with “FUNRx AI Platform” – A New Era of Smarter, Predictive and High-Quality Healthcare
https://www.otcmarkets.com/stock/FUNR/news/FU...?id=483979
La Jolla, California – June 26, 2025 – FUNR (the Company) (OTCPK: FUNR) is on the brink of revolutionizing telemedicine with the launch of its next-gen "FUNRx Platform", a bold fusion of cutting-edge telemedicine, artificial intelligence, and in-house pharmaceutical production. The Company has finalized a Strategic Revenue Share and Equity Partnership with Nutra Custom Corp., positioning FUNR to lead the future of healthcare delivery.
This game-changing partnership will combine telemedicine services with advanced pharmaceutical manufacturing, creating a disruptive platform that offers unmatched convenience, predictive care, and superior quality. FUNRx isn’t just a service – it's a new standard in how healthcare is delivered, offering personalized, proactive care that anticipates patient needs before they arise.
Under the leadership of CEO Ethan Zachadnyk, FUNR is reimagining patient care, blending licensed medical professionals with cutting-edge AI to deliver smarter, faster and more effective healthcare. This is more than just telemedicine; it's the future of a holistic healthcare ecosystem designed to deliver long-term value and change the lives of patients.
“With FUNRx, we’re not just offering telemedicine, we’re setting a new benchmark for the entire healthcare industry,” said CEO Ethan Zachadnyk. “This platform will give patients access to smarter, more personalized care, while creating significant value for our shareholders.”
“We are thrilled to partner with FUNR and be part of this transformative shift in healthcare,” said Dr. Mark Forster, CEO and Founder of Nutra Custom. “This collaboration merges our expertise in pharmaceutical production with their innovative telemedicine platform, and together, we’re poised to redefine the future of personalized, predictive healthcare.”
https://www.otcmarkets.com/stock/FUNR/news/FU...?id=483979
La Jolla, California – June 26, 2025 – FUNR (the Company) (OTCPK: FUNR) is on the brink of revolutionizing telemedicine with the launch of its next-gen "FUNRx Platform", a bold fusion of cutting-edge telemedicine, artificial intelligence, and in-house pharmaceutical production. The Company has finalized a Strategic Revenue Share and Equity Partnership with Nutra Custom Corp., positioning FUNR to lead the future of healthcare delivery.
This game-changing partnership will combine telemedicine services with advanced pharmaceutical manufacturing, creating a disruptive platform that offers unmatched convenience, predictive care, and superior quality. FUNRx isn’t just a service – it's a new standard in how healthcare is delivered, offering personalized, proactive care that anticipates patient needs before they arise.
Under the leadership of CEO Ethan Zachadnyk, FUNR is reimagining patient care, blending licensed medical professionals with cutting-edge AI to deliver smarter, faster and more effective healthcare. This is more than just telemedicine; it's the future of a holistic healthcare ecosystem designed to deliver long-term value and change the lives of patients.
“With FUNRx, we’re not just offering telemedicine, we’re setting a new benchmark for the entire healthcare industry,” said CEO Ethan Zachadnyk. “This platform will give patients access to smarter, more personalized care, while creating significant value for our shareholders.”
“We are thrilled to partner with FUNR and be part of this transformative shift in healthcare,” said Dr. Mark Forster, CEO and Founder of Nutra Custom. “This collaboration merges our expertise in pharmaceutical production with their innovative telemedicine platform, and together, we’re poised to redefine the future of personalized, predictive healthcare.”
(0)
(0)
